{"id":"https://openalex.org/W2414800007","doi":null,"title":"Can cytotoxic activity of anthracyclines be related to DNA damage?","display_name":"Can cytotoxic activity of anthracyclines be related to DNA damage?","publication_year":1990,"publication_date":"1990-02-01","ids":{"openalex":"https://openalex.org/W2414800007","mag":"2414800007","pmid":"https://pubmed.ncbi.nlm.nih.gov/2317255"},"language":"en","primary_location":{"id":"pmid:2317255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2317255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Comparative Study"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007384987","display_name":"Masahiko Nishiyama","orcid":"https://orcid.org/0000-0001-9731-7183","observed_orcids":["https://orcid.org/0000-0001-9731-7183"]},"institutions":[{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Nishiyama","raw_affiliation_strings":["Laboratoire de Pharmacologie Cellulaire et Mol\u00e8culaire, ICIG, H\u00f4pital Paul Brousse, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie Cellulaire et Mol\u00e8culaire, ICIG, H\u00f4pital Paul Brousse, Villejuif, France","institution_ids":["https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014820716","display_name":"Naoya Horichi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Horichi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074467134","display_name":"Zohra Mazouzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Mazouzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108699836","display_name":"M Bungo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bungo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111462586","display_name":"N Saijo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Saijo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034625557","display_name":"Ha\u00efm Tapiero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Tapiero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2851,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.55328845,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"5","issue":"1","first_page":"135","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7534000277519226,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.1817999929189682,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.023099999874830246,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.9879999756813049},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pirarubicin","display_name":"pirarubicin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/m1-metabolite","display_name":"M1 metabolite","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.7200000286102295},{"id":"https://openalex.org/keywords/single-strand-breaks","display_name":"single-strand breaks","score":0.7559999823570251},{"id":"https://openalex.org/keywords/dna-protein-cross-linking","display_name":"DNA-protein cross-linking","score":0.8610000014305115},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.781000018119812},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6510000228881836},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.656000018119812},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.9729999899864197},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6800000071525574},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.8454560041427612},{"id":"https://openalex.org/C2776085618","wikidata":"https://www.wikidata.org/wiki/Q3905585","display_name":"Pirarubicin","level":3,"score":0.789039134979248},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7585256099700928},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.7502144575119019},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.7376235723495483},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5693134665489197},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5317116379737854},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5129866003990173},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4086897075176239},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.39035215973854065},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3371971547603607},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3252212107181549},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22365513443946838},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08327749371528625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.04904857277870178},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2317255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2317255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Comparative Study"},{"id":"mag:2414800007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2317255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1609249656","https://openalex.org/W2126218359","https://openalex.org/W2128590787","https://openalex.org/W2085697102","https://openalex.org/W2049913223","https://openalex.org/W2130199714","https://openalex.org/W2419298103","https://openalex.org/W2037127916","https://openalex.org/W2409651531","https://openalex.org/W3036515335"],"abstract_inverted_index":{"Accumulation,":[0],"cytotoxicity,":[1],"and":[2,28,62,135],"DNA":[3,59,89,95,105,136,148],"damages":[4],"produced":[5,87,107,140],"by":[6,36,108,141],"doxorubicin":[7],"(DOX),":[8],"pirarubicin":[9],"(THP-DOX),":[10],"fluoro-doxorubicin":[11],"(ME2303)":[12],"or":[13,45,69,82,158],"its":[14],"isolated":[15],"metabolite":[16],"M1":[17,159],"have":[18],"been":[19],"investigated":[20],"in":[21,101,115],"human":[22],"myelogenous":[23],"leukemia":[24],"cells,":[25,53],"sensitive":[26],"(K562)":[27],"resistant":[29],"to":[30,58,129,154],"DOX":[31,68],"(K562/DOX).":[32],"These":[33],"compounds":[34],"differed":[35],"lipophilicity":[37],"and/or":[38],"sugar":[39],"moiety":[40],"either":[41],"with":[42,80,147,162,168],"(DOX,":[43],"THP-DOX)":[44],"without":[46],"(ME2303,":[47],"M1)":[48],"amino":[49],"group.":[50],"In":[51,84,92],"K562":[52,93],"the":[54,63,76,169],"cytotoxicity":[55,134,139],"was":[56,72,97,120,127],"correlated":[57],"single-stranded":[60],"breaks":[61],"intracellular":[64,124],"drug":[65,118,125,164],"amount":[66],"of":[67,104,133,152],"M1.":[70],"This":[71],"not":[73,98,144],"true":[74],"when":[75],"cells":[77,94,117],"were":[78],"treated":[79],"THP-DOX":[81,86],"ME2303.":[83],"addition,":[85],"total":[88],"protein":[90],"cross-linking.":[91],"damage":[96,106],"repaired,":[99],"while":[100],"K562/DOX":[102,116],"repair":[103],"all":[109],"drugs":[110],"could":[111],"be":[112],"observed.":[113],"Although":[114],"accumulation":[119,165],"much":[121],"reduced,":[122],"higher":[123],"concentration":[126],"required":[128],"induce":[130],"similar":[131],"level":[132,151],"damage.":[137,149],"Thus,":[138],"anthracycline":[142],"is":[143,160],"always":[145],"associated":[146,161],"Different":[150],"resistance":[153],"DOX,":[155],"THP-DOX,":[156],"ME2303":[157],"reduced":[163],"which":[166],"varies":[167],"structure.":[170]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}